Dr Helen Ke is a medical oncologist with special interest in breast, genitourinary and thoracic cancers.  Dr Ke was born in Sydney and obtained her medical degree from the University of New South Wales.  She completed her subspecialty training in Medical Oncology at the Chris O'Brien Lifehouse (RPA) and Concord Hospitals.  Dr Ke has furthermore obtained additional training (Clinical Diploma) in Palliative Medicine through the Royal Australasian College of Physicians, through which she further enhanced her skills in complex symptom management and delivery of compassionate and evidence-based care in challenging clinical situations.

Dr Helen Ke believes medical oncologists have a special duty for compassion, candour and sensitivity and upholds these principles in her practice.  She is committed to the delivery of personalised care,using an evidence based and collaborative multi-disciplinary approach.  Dr Ke spent two years as a Research Fellow with the Australian Rare Cancers Portal (ARC Portal, Royal Melbourne Hospital) and is the current Precision Oncology Fellow at The Prince of Wales Hospital, further developing her practice in this highly personalised, molecularly based approach to medical oncological practice.

She remains committed to development in research and teaching.  Dr Helen Ke is a course coordinator for the Masters of Medicine program at Sydney University for the past 3 years, teaching post-graduate medical doctors, and is a PhD candidate at Sydney University investigating liquid biopsies, biomarkers and novel therapies in patients with mesothelioma.

She has professional Associations with the American Society of Clinical Oncology (ASCO), European Society of Medical Oncology (ESMO), Medical Oncology Group of Australia (MOGA) and Thoracic Oncology Group of Australia (TOGA).